These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6374298)

  • 1. [Platelet aggregation and PAF-acether. Pharmacologic interference].
    Vargaftig BB; Fouque F; Lefort J
    J Pharmacol; 1984; 15 Suppl 1():69-84. PubMed ID: 6374298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
    Nunez D; Russo-Marie F; Benveniste J
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
    Wal F; Joseph D; Touqui L; Vargaftig BB
    Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB; Joseph D; Marlas G; Chevance LG
    Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent.
    Vargaftig BB; Fouque F; Joseph D; Odiot J; Benveniste J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():429-33. PubMed ID: 6221558
    [No Abstract]   [Full Text] [Related]  

  • 6. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
    Keraly CL; Benveniste J
    Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators.
    Fourcade O; Simon MF; Litt L; Samii K; Chap H
    Anesth Analg; 2004 Aug; 99(2):393-8, table of contents. PubMed ID: 15271713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.
    Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH
    J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paf-acether (platelet-activating factor).
    Benveniste J
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():11-8. PubMed ID: 3159192
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-platelet activating factor property of Rubia cordifolia Linn.
    Tripathi YB; Pandey S; Shukla SD
    Indian J Exp Biol; 1993 Jun; 31(6):533-5. PubMed ID: 8406601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombocyte aggregation inhibitors. A new class of active substances].
    Böhm R; Giessler AJ
    Pharmazie; 1986 Jan; 41(1):1-7. PubMed ID: 3515372
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenaline/PAF acether synergism on human platelets: involvement of Hydergine.
    Fouque F; Vargaftig BB
    J Pharmacol; 1985; 16 Suppl 3():129-34. PubMed ID: 4094442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mepyramine inhibits platelet activating factor-induced rabbit platelet aggregation: role of intracellular histamine.
    Zeng S; Guo ZG
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):155-8. PubMed ID: 10072970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
    Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
    Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
    Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
    J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of platelet-activating factor (PAF) on the collagen-induced whole blood aggregation].
    Oura Y
    Rinsho Byori; 1994 Jan; 42(1):63-9. PubMed ID: 8107285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelet aggregation and platelet activating factor (author's transl)].
    Chignard M; Vargaftig BB; Benveniste J; Le Couedic JP
    J Pharmacol; 1980; 11(4):371-7. PubMed ID: 7206730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells.
    Pirotzky E; Ninio E; Bidault J; Pfister A; Benveniste J
    Lab Invest; 1984 Nov; 51(5):567-72. PubMed ID: 6492758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion.
    Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH
    J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats.
    Bocheński J; Chłopicki S; Gryglewski RJ
    J Physiol Pharmacol; 1999 Jun; 50(2):287-97. PubMed ID: 10424723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.